Case records of the Massachusetts General Hospital. Case 31-2005. A 60-year-old man with skin lesions and renal insufficiency by Kay, Jonathan & McCluskey, Robert T.
University of Massachusetts Medical School 
eScholarship@UMMS 
Rheumatology Publications and Presentations Rheumatology 
2005-10-13 
Case records of the Massachusetts General Hospital. Case 
31-2005. A 60-year-old man with skin lesions and renal 
insufficiency 
Jonathan Kay 
University of Massachusetts Medical School Worcester 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/rheumatology_pubs 
 Part of the Male Urogenital Diseases Commons, Rheumatology Commons, and the Skin and 
Connective Tissue Diseases Commons 
Repository Citation 
Kay J, McCluskey RT. (2005). Case records of the Massachusetts General Hospital. Case 31-2005. A 
60-year-old man with skin lesions and renal insufficiency. Rheumatology Publications and Presentations. 
https://doi.org/10.1056/NEJMcpc059026. Retrieved from https://escholarship.umassmed.edu/
rheumatology_pubs/142 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Rheumatology 
Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please 
contact Lisa.Palmer@umassmed.edu. 
 n engl j med 
 
353;15
 
www.nejm.org october 
 
13, 2005
 
The
 
 new england journal 
 
of
 
 medicine
 
1605
 
case records 
 
of the
 
 
 
massachusetts general hospital
 
Founded by
 
 Richard C. Cabot
Nancy Lee Harris, 
 
m.d.,
 
 
 
Editor
 
Jo-Anne O. Shepard, 
 
m.d.
 
, 
 
Associate Editor
 
Stacey M. Ellender, 
 
Assistant Editor
 
Sally H. Ebeling, 
 
Assistant Editor
 
Christine C. Peters, 
 
Assistant Editor
 
Case 31-2005: A 60-Year-Old Man with Skin 
Lesions and Renal Insufficiency
 
Jonathan Kay, M.D., and Robert T. McCluskey, M.D.
 
From the Rheumatology Unit (J.K.) and the
Department of Pathology (R.T.M.), Mas-
sachusetts General Hospital; and the De-
partments of Medicine (J.K.) and Pathology
(R.T.M.), Harvard Medical School — both
in Boston.
N Engl J Med 2005;353:1605-13.
 
Copyright © 2005 Massachusetts Medical Society.
 
A 60-year-old man was evaluated in the rheumatology clinic because of a rash and
worsening renal function.
He had been well until three months earlier, when he began to have fatigue and
weight gain, one week after returning from a visit to his son in Colorado. He could not
fit into his shoes, and his wife noticed that he had facial swelling. Three days later, a
rash appeared over his buttocks and feet. He saw his primary care physician. The blood
pressure was 154/82 mm Hg. There was 1+ bilateral pretibial and pedal edema. Tests
for antineutrophil cytoplasmic antibodies and anti–streptolysin O were negative; a test
for antinuclear antibodies was weakly positive (8 U; normal, less than 7.5 U). Other lab-
oratory-test results are listed in Tables 1 and 2. The results of chest radiography
showed no abnormalities, except for blunting of the costophrenic angles that was
thought to represent small effusions. An ultrasonographic study of the kidneys re-
vealed hypoechoic areas in the left kidney and a normal-appearing right kidney. Furo-
semide and metolazone were started. A low titer of IgM antibody to Rocky Mountain
spotted fever was present, but this value did not change on follow-up testing.
Despite increasing doses of furosemide, the patient continued to gain weight over
the course of the next 10 days. He was referred to a nephrologist at another hospital.
The blood pressure was 175/95 mm Hg, and he had gained more than 9 kg since the
start of his illness. Palpable purpuric lesions were present on the buttocks and feet, in-
cluding the soles. The serum creatinine level was 2.1 mg per deciliter (185.6 µmol per
liter), and the urinalysis revealed 3+ protein, 4+ blood, 10 to 15 red cells per high-power
field, 5 to 10 white cells per high-power field, and many coarse and fine granular casts.
Treatment with atenolol was started. A skin-biopsy specimen showed a leukocytoclas-
tic vasculitis. Direct immunofluorescence staining of the biopsy specimen showed gran-
ular deposits consisting primarily of IgM and C3 in a vascular pattern in the papillary
dermis, with very faint deposits of IgG and no IgA.
A renal biopsy was performed one week later at that hospital, and a diagnosis of en-
docapillary proliferative glomerulonephritis, immune-complex type, was made. Immu-
nofluorescence studies were reported to show mesangial and focal capillary-loop depos-
its of IgG, C3 (trace to 1+), and IgM (1+). Electron-microscopical examination revealed
small mesangial and subendothelial electron-dense deposits. The findings were con-
presentation of case
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sidered consistent with postinfectious glomerulo-
nephritis, provided that other types of immune-
complex glomerulonephritis could be ruled out —
in particular, lupus nephritis. Over the next two
weeks, the patient continued to be fatigued, with a
poor appetite; the serum creatinine level rose to a
peak of 2.9 mg per deciliter (256.4 µmol per liter).
Treatment with prednisone (60 mg per day), li-
sinopril, amlodipine, and omeprazole was started,
and treatment with metolazone was discontinued.
The patient was also still taking furosemide and
atenolol. Over the next four weeks, the serum cre-
atinine level fell to 1.9 mg per deciliter (167.9 µmol
per liter), the patient’s edema improved, the rash
gradually resolved, and he felt more energetic. Dur-
ing the next week, however, the edema increased,
and over the course of the next four weeks the cre-
atinine level rose to 2.4 mg per deciliter (212.2 µmol
per liter). A 24-hour urine collection yielded 5.7 g
per deciliter of protein. Three weeks later, the pa-
tient was seen in the rheumatology clinic of this
hospital.
The patient was a retired management consult-
ant who lived in New Hampshire. He did not have
photosensitivity, hair loss, Raynaud’s phenome-
non, keratoconjunctivitis sicca symptoms, or ar-
thritis. An appendectomy had been performed two
years earlier because of acute appendicitis. He
drank approximately five alcoholic beverages per
week and did not smoke cigarettes. He had no al-
lergies. There was no family history of renal dis-
ease or autoimmune disorders. He was married,
and his wife and a son and a daughter were well. He
knew of no exposures to toxins or ill persons and
did not recall tick bites. He had traveled recently
only to Colorado and Connecticut.
On examination, he appeared chronically ill. The
blood pressure was 170/100 mm Hg, the pulse 60
beats per minute, and the respiratory rate 14 breaths
per minute. He had a cushingoid appearance, and
there was diffuse anasarca. There was marked (4+)
pitting edema of both forearms and of both legs,
extending up to the thighs. The results of the re-
mainder of the physical and neurologic examina-
tions were normal.
Laboratory-test results are shown in Tables 1
and 2. A diagnostic test was performed.
 
Dr. Jonathan Kay: 
 
I participated in the care of this pa-
tient and am aware of the diagnosis. This 60-year-
differential diagnosis
 
* To convert the values for creatinine to micromoles per liter, multiply by 88.4. 
To convert the values for blood urea nitrogen to millimoles per liter, multiply 
 
by 0.357.
 
Table 1. Blood Chemical Values.*
Variable
3  Months 
before 
Evaluation
On 
Rheumatologic 
Evaluation
Normal 
Range
 
Creatinine (mg/dl) 1.9 2.4 0.8–1.3
Blood urea nitrogen (mg/dl) 45 100 4–23
Potassium (mmol/liter) 5.7 4.1 3.6–5.2
Sodium (mmol/liter) 136 143 136–145
Albumin (g/dl) 3.3 2.6 3.4–5.0
Alkaline phosphatase (U/liter) 57 45–115
Aspartate aminotransferase 
(U/liter)
54 10–55
 
* GPL denotes IgG phospholipid, and MPL IgM phospholipid.
 
Table 2. Hematologic and Immunologic Laboratory Values.*
Variable
3  Months 
before 
Evaluation
On 
Rheumatologic 
Evaluation
Normal 
Range
 
Anticardiolipin IgG 
(GPL units)
2.2 1–15
Anticardiolipin IgM
(MPL units)
24.2 1–15
Rheumatoid factor (U/ml) 173 <30
C3 complement (mg/dl) 42 58 85–200
C4 complement (mg/dl) 3 <10 14–53
Total serum complement 
(U/ml)
<3 86–184
Cryoglobulins Negative Negative
Hepatitis B surface antigen Negative
Hepatitis C antibody Negative
Hematocrit (%) 29.7 29.0 40–54
White-cell count (per mm
 
3
 
) 10,290 13,100 4000–10,800
Platelet count (per mm
 
3
 
) 152,000 216,000 150,000–350,000
Erythrocyte sedimentation 
rate (mm/hr)
3 28 0–17
Urinalysis
 Albumin 3+ 3+ Negative
 Blood 4+ 3+ Negative
 Red cells 10–15 10–50 0–2
 White cells 5–12 0 0–2
 Granular casts Many 0–2 Negative
 Hyaline casts Many 0–2 0–5
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old man had a sudden onset of constitutional symp-
toms; leukocytoclastic cutaneous vasculitis; facial,
arm, and leg edema; and hypertension, within two
weeks after returning from a visit to Colorado. Lab-
oratory evaluation revealed anemia and renal insuf-
ficiency, with microscopic hematuria and protein-
uria in the nephrotic range. Serum complement
levels were decreased, and he had low titers of anti-
nuclear antibodies and of IgM antibodies to Rocky
Mountain spotted fever. Testing for cryoglobulins
and antineutrophil cytoplasmic antibodies had been
negative.
The development of a palpable purpuric rash
shortly after the patient’s return from Colorado
raised the possibility of Rocky Mountain spotted fe-
ver. Early symptoms of Rocky Mountain spotted fe-
ver, which usually occur several days to two weeks
after the bite of a common dog tick (
 
Dermacentor vari-
abilis
 
) infected with 
 
Rickettsia rickettsii
 
, include fever,
headache, malaise, myalgias, nausea with or with-
out vomiting, and abdominal pain. The patient did
not describe any of these symptoms. The patient’s
rash was located on his chest, buttocks, and legs, in
contrast to the typical distribution of the rash of
Rocky Mountain spotted fever, which usually be-
gins as a maculopapular eruption that evolves into
a petechial rash on the arms and legs and then
spreads centrally and also distally to the palms and
soles. About 20 percent of patients have renal in-
volvement. The diagnosis can be made by serologic
testing that shows a titer of 1:128 or higher. This
patient’s titer of IgM antibodies was 1:64, and the
result did not change on follow-up testing, suggest-
ing that Rocky Mountain spotted fever was not the
cause of his illness.
This patient’s urinary sediment contained red
cells, suggesting glomerular disease. The presence
of nephrotic-range proteinuria, hypertension, ede-
ma, and elevated serum levels of creatinine imply
diffuse glomerulonephritis, in which inflammatory
lesions are present in most or all of the glomeruli
on light microscopical examination. The results of
a renal biopsy reportedly showed endocapillary pro-
liferative glomerulonephritis with immune com-
plexes containing IgG, IgM, and C3.
The pathologist who interpreted the renal biopsy
raised the possibility of either postinfectious glo-
merulonephritis or lupus nephritis. Antistreptolysin
O antibodies were not detected, which ruled out a
diagnosis of poststreptococcal glomerulonephritis.
Although the initial test for antinuclear antibod-
ies was weakly positive, the test repeated at this
hospital was negative. About 5 percent of patients
with systemic lupus erythematosus present without
detectable serum antinuclear antibodies
 
1
 
; howev-
er, these patients typically do not have renal involve-
ment. When nephrotic-range proteinuria develops
in a patient with lupus nephritis, serum antinuclear
antibodies may become undetectable because they
are excreted with other proteins in the urine; this
scenario was a possibility in this patient. He report-
edly had IgM anticardiolipin antibodies and hypo-
complementemia, both of which are features asso-
ciated with lupus. If the findings of the renal biopsy
had been consistent with lupus nephritis, he would
have met only three of the four criteria necessary
for a diagnosis of systemic lupus erythematosus, as
defined in 1997 by the American College of Rheu-
matology.
 
2
 
 Thus, a diagnosis other than systemic
lupus erythematosus should be considered.
The 1994 Chapel Hill consensus conference on
the nomenclature of systemic vasculitides
 
3
 
 divided
this group of disorders into large-vessel vasculitis,
medium-sized–vessel vasculitis, and small-vessel
vasculitis (vasculitis involving vessels smaller than
arteries). The disease in the patient under discus-
sion clinically involved arterioles, capillaries, and
venules, since there was cutaneous leukocytoclas-
tic vasculitis and glomerulonephritis. Many causes
of small-vessel vasculitis could be ruled out in this
patient because of the absence of predisposing fac-
tors, such as exposure to drugs or documented in-
fections, or the absence of associated diseases.
 
4
 
There was no evidence of cancer, inflammatory
bowel disease, rheumatoid arthritis, or Sjögren’s
syndrome. He did not have urticaria, which might
have suggested hypocomplementemic urticarial
vasculitis. There were no oral or genital ulcerations,
involvement of the central nervous system, or uveitis
to suggest Behçet’s disease, and no pulmonary in-
volvement to suggest Goodpasture’s syndrome. Mi-
croscopic polyangiitis, Wegener’s granulomatosis,
and the Churg–Strauss syndrome are unlikely diag-
noses in the absence of antineutrophil cytoplas-
mic antibodies. Thus, the most likely diagnosis was
Henoch–Schönlein purpura or cryoglobulinemic
vasculitis.
Henoch–Schönlein purpura typically affects chil-
dren, with the peak incidence at around five years
of age, but it also may affect adults. The disease
usually occurs not only with nephritis and palpable
purpura that typically involves the lower extremi-
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ties, but also with gastrointestinal symptoms, such
as abdominal pain, which this patient did not have.
In both Henoch–Schönlein purpura and cryoglob-
ulinemic vasculitis, cutaneous involvement occurs
in about 90 percent of patients and renal involve-
ment in about 50 percent.
 
4
 
 However, IgA deposition
in the skin, which is pathognomonic of Henoch–
Schöelein purpura, was not present in this case.
Laboratory findings in this patient that support
a diagnosis of cryoglobulinemic vasculitis include
hypocomplementemia with low levels of C4 and the
presence of rheumatoid factor without antinuclear
antibodies. In patients with mixed cryoglobuline-
mia, serum complement activation results in selec-
tive depression of the C4 level, often to below the
limit of detection
 
5
 
; this occurs most frequently in
those with type II cryoglobulins.
 
6
 
 Type II cryoglob-
ulins contain a monoclonal component, often an
IgM rheumatoid factor, and polyclonal IgG.
 
7
 
 Renal
involvement is three times as prevalent in patients
with type II mixed cryoglobulinemia as in those
with type III mixed cryoglobulinemia,
 
6
 
 in which the
cryoglobulins contain a combination of polyclonal
IgM rheumatoid factor and polyclonal IgG.
 
7
 
 How-
ever, cryoglobulins were not detected in this pa-
tient’s blood.
Since the hallmark of cryoglobulinemia is the
presence of cryoglobulins, how could a negative
cryoglobulin determination be consistent with this
diagnosis? The assay for cryoglobulins involves
careful handling of the blood sample: the specimen
must be maintained between 37°C and 41°C from
the time of its withdrawal until the serum is isolat-
ed in the laboratory. After centrifugation at 37°C to
remove red cells and fibrin, the serum is transferred
at room temperature to a cryocrit tube, which then
is stored at 4°C for a week and observed daily for
seven days. If the serum becomes cloudy, the cry-
ocrit tube is centrifuged in the cold and the cryocrit
is measured. The cryoglobulin is washed and then
assessed for monoclonality by immunofixation and
for the presence of rheumatoid factor. If the speci-
men is exposed to temperatures lower than 37°C at
any time before the serum is obtained, the cryopre-
cipitate may be lost. Thus, improper handling of the
specimen before it reaches the clinical laboratory or
improper processing in the laboratory can result in
a false negative cryoglobulin test.
In summary, my diagnosis in this case is type II
mixed cryoglobulinemia, with a false negative cry-
oglobulin assay. I requested that the renal-biopsy
specimen be reviewed by our renal pathologists.
 
Dr. Nancy Lee Harris
 
 (Pathology): Dr. Franklin Se-
gall referred the patient to Dr. Kay. Could you com-
ment on your thinking?
 
Dr. Franklin D. Segall
 
 (Nephrology, Mount Auburn
Hospital): When I first saw the patient, the urine
sediment suggested glomerular inflammation. Be-
cause of the rash, I considered Henoch–Schönlein
purpura and obtained a skin-biopsy specimen,
which showed no IgA deposition. When the renal
biopsy suggested lupus nephritis, I started the pa-
tient on steroid treatment; he had initial improve-
ment, but his renal function continued to deterio-
rate, and I sent him to see Dr. Kay.
Glomerulonephritis due to systemic lupus erythe-
matosus.
Mixed cryoglobulinemia type II.
 
Dr. Robert T. McCluskey: 
 
The diagnostic procedure
was a review of the renal biopsy performed at the
other hospital. All of the glomeruli in the specimen
were globally hypercellular, owing almost entirely
to intracapillary cells with the appearance of mono-
cytes or macrophages (Fig. 1A). Periodic acid–
Schiff (PAS) preparations showed generally normal-
appearing glomerular basement membranes, with
rare segmental duplication of the glomerular base-
ment membrane and without an appreciable in-
crease in mesangial matrix. Several glomeruli had
one or more intracapillary amorphous, eosinophil-
ic, PAS-positive globules, which are characteristic
of pseudothrombi (Fig. 1A). There was mild, focal
interstitial mononuclear-cell infiltration and edema.
Two small arteries had features of vasculitis (Fig.
1B and 1C). A review of the electron micrographs
of one glomerulus revealed amorphous, electron-
dense subendothelial and intracapillary deposits,
as well as segmental duplication of the glomeru-
lar basement membrane (Fig. 1D). Intracapillary
mononuclear cells were also seen. Immunofluo-
rescence microscopical studies were reported as
showing trace to 1+ granular staining for IgM, IgG,
and C3, without IgA, in the mesangium and along
the glomerular basement membranes.
The renal-biopsy findings are highly character-
clinical diagnosis
dr.  jonathan kay’s  diagnosis
pathological discussion
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istic of active, acute type II mixed cryoglobulinemic
glomerulonephritis (Table 3). The key features are
massive accumulation of monocytes and macro-
phages in glomeruli and the presence of pseudo-
thrombi.
 
8-10
 
 Although the intracapillary leukocytes
have the appearance of monocytes or macrophages
in histologic preparations, more definitive cell iden-
tification might have been obtained through the use
of a monocyte marker, notably CD68.
 
8
 
 The finding
on immunofluorescence microscopy of granular de-
posits in glomeruli containing IgM and IgG is con-
sistent with mixed cryoglobulin complexes. The
finding of small-vessel vasculitis adds additional
support to the diagnosis; in particular, the accu-
mulation of amorphous eosinophilic material in a
vessel wall (Fig. 1C), which probably represents
cryoprecipitates, is characteristic of early cryoglob-
ulinemic vasculitis. The electron-microscopical
findings also favor the diagnosis of cryoglobuline-
mic glomerulonephritis by showing intraluminal
and subendothelial deposits, as well as intracapil-
lary cells with the appearance of monocytes. In this
case, the glomerular electron-dense deposits were
amorphous, which is not unusual in cryoglobuline-
mic glomerulonephritis. However, in many cases
the deposits have distinctive fibrillar or cylindrical
structures that are virtually diagnostic of type II
mixed cryoglobulinemic glomerulonephritis.
 
11
 
The initial pathologic diagnosis made in the
present case was endocapillary proliferative glo-
merulonephritis. This is a descriptive term that
A
B
C
D
**
 
Figure 1. Renal-Biopsy Specimen.
 
The glomerulus (Panel A) is globally hypercellular, with 
numerous intracapillary mononuclear cells. An amor-
phous intracapillary deposit is seen (arrow), as well as 
segmental duplication of the glomerular basement 
membrane (periodic acid–Schiff staining). Amorphous 
eosinophilic material (Panel B) occupies the lumen and 
much of the wall of a small vessel, accompanied by 
perivascular fibrosis and inflammation (hematoxylin and 
eosin). A small artery (Panel C) has intimal thickening 
with scattered infiltrating mononuclear cells, together 
with segmental medial disruption (arrows) and perivas-
cular fibrosis, indicating vasculitis (hematoxylin and 
eosin). An electron micrograph (Panel D) reveals large, 
globular, amorphous, electron-dense deposits (arrow), 
as well as small subendothelial dense deposits (arrow-
head) and segmental duplication of the glomerular base-
ment membrane (asterisks).
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was introduced in early studies
 
12
 
 of renal-biopsy
specimens, when it was believed that glomerular
hypercellularity resulted mainly from proliferation
of mesangial and endothelial cells. However, it was
later shown that infiltration by circulating mono-
cytes, rather than the proliferation of endothelial
cells, largely accounts for endocapillary hypercel-
lularity in various forms of glomerulonephritis.
 
8-10
 
The numbers of intraglomerular monocytes and
macrophages are far greater in acute type II mixed
cryoglobulinemic glomerulonephritis than in other
so-called proliferative conditions, notably post-
streptococcal glomerulonephritis, diffuse prolif-
erative lupus nephritis, and idiopathic membra-
noproliferative glomerulonephritis type I.
 
8-10
 
 The
mononuclear cells phagocytose and degrade the
IgM and IgG mixed cryoglobulin complexes with-
in glomeruli, thus helping to bring about resolu-
tion, but they also contribute to glomerular injury
through a variety of mechanisms, including the
release of proteases, reactive oxygen species, ei-
cosanoids, and nitric oxide.
 
13
 
A skin-biopsy specimen of a purpuric lesion
showed leukocytoclastic vasculitis (Fig. 2). The ab-
sence of IgA in the vascular lesions argues against
the diagnosis of Henoch–Schönlein purpura, and
the finding of deposits of IgM, IgG, and C3 sup-
ports the diagnosis of mixed cryoglobulinemic vas-
culitis. However, the diagnostic pathological find-
ings were in the kidney. A biopsy specimen of the
bone marrow obtained at this hospital was normal.
 
Dr. Kay: 
 
After Dr. McCluskey’s review of the renal
biopsy, blood was drawn under appropriate condi-
tions to assess for cryoglobulins. The cryocrit was
3 percent, with a cryoglobulin that consisted of ho-
mogeneous IgM kappa and heterogeneous IgG
protein — findings that established the diagnosis
of type II mixed cryoglobulinemia.
Since the association between hepatitis C virus
infection and mixed cryoglobulinemia was first re-
ported,
 
14
 
 type II mixed cryoglobulinemia associat-
ed with hepatitis C virus infection has become the
type of cryoglobulinemia that is most commonly
encountered in clinical practice (in 80 percent of
the cases).
 
6
 
 This patient’s serum contained no an-
tibodies to hepatitis C virus and no hepatitis C viral
messenger RNA (mRNA) was detectable by poly-
merase-chain-reaction assay of his serum. However,
because hepatitis C viral mRNA may be concentrat-
ed up to 1000 times within the cryoprecipitate,
 
15
 
the polymerase-chain-reaction assay for hepatitis C
viral mRNA was performed on the cryoprecipitate
by Dr. Vincent Agnello at the Lahey Clinic in Burl-
ington, Massachusetts, and was negative. This re-
sult confirmed that the patient had type II mixed
cryoglobulinemia, unassociated with hepatitis C vi-
rus infection.
 
Dr. Kay:
 
 A prospective randomized, controlled clin-
ical trial of treatment for cryoglobulinemia associ-
ated with hepatitis C virus infection
 
16
 
 found that
interferon alfa-2a resulted in disappearance of de-
tectable hepatitis C viral mRNA from the serum and
improvement in the serum levels of cryoglobulin
and signs and symptoms of cryoglobulinemia in
15 of 25 patients (60 percent) who were treated
with interferon alfa-2a. However, treatment of cry-
oglobulinemia without hepatitis C virus infection
remains based on empirical clinical experience, al-
though one study showed a response to recombi-
nant interferon alfa-2a in two patients.
 
17
 
If the patient has an underlying condition that is
contributing to cryoglobulin production, such as a
hematologic cancer, that condition should be treat-
discussion of management
 
Table 3. Distinctive Pathological Features of Type II Mixed Cryoglobulinemic 
Glomerulonephritis.
Acute stage (as in first biopsy specimen)
 
Massive infiltration of glomeruli by activated monocytes and macrophages 
(CD68 positive, esterase positive)
Intracapillary deposits testing positive on periodic acid–Schiff staining; 
containing IgM and IgG, characteristic of cryoglobulin precipitates 
(pseudothrombi)
Electron-dense intracapillary, intramonocyte, and subendothelial deposits, 
some with fibrillar or cylindrical structure
Segmental duplication of glomerular basement membrane and mild-to-
moderate mesangial increase
Small-vessel vasculitis
IgG and IgM deposits in the interstitium (not described in this case)
 
Chronic stage (as in second biopsy specimen)
 
Pattern of membranoproliferative glomerulonephritis type I
Moderate increase in mesangial cells and matrix, with prominent duplication 
of glomerular basement membranes; tubular atrophy and interstitial 
fibrosis
Few or no monocytes in glomeruli
Few, if any, pseudothrombi
Deposits in mesangial cells and in glomerular basement membrane contain-
ing IgM, IgG, and C3 (often sparse)
Subendothelial and mesangial electron-dense deposits, with or without fibril-
lar or tubular substructure
Evidence of healed vasculitis
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ed. Plasmapheresis may be used as short-term treat-
ment to remove circulating cryoglobulins and to
prevent their deposition in tissues. Immunosup-
pressive therapy with prednisone and cytotoxic
drugs, such as cyclophosphamide, usually is initi-
ated to suppress cryoglobulin production.
Rituximab, an anti-CD20 chimeric monoclonal
antibody that depletes B cells, was used recently to
treat patients who had mixed cryoglobulinemia
that was unresponsive to other medications. In two
prospective, uncontrolled case series involving 35
patients, including 3 without hepatitis C infec-
tion,
 
18,19
 
 serum levels of cryoglobulin decreased,
serum levels of C4 increased, and there was clinical
improvement in the majority of the patients. How-
ever, hepatitis C viral mRNA levels increased in
some of the patients in each of these series. Thus,
caution must be used when treating patients who
have hepatitis C virus infection with rituximab.
Despite treatment with 20 mg of oral predni-
sone three times daily, this patient’s creatinine level
rose to 2.4 mg per deciliter (212.2 µmol per liter)
after eight weeks of the drug. Cyclophosphamide
(800 mg) was administered in a single intravenous
dose, and plasmapheresis was begun (total, six
treatments). The course of his disease was compli-
cated with an infection with 
 
Staphylococcus aureus
 
 that
caused septic prepatellar bursitis, requiring hospi-
talization for intravenous penicillin therapy for
the penicillin-sensitive 
 
S. aureus
 
 and closed drain-
age; an episode of bronchiolitis obliterans with or-
ganizing pneumonitis that was diagnosed by vid-
eo-assisted thoracoscopy; an empyema of the right
lung associated with 
 
Escherichia coli
 
 that required
chest-tube drainage and intravenous antibiotics;
and a perforated sigmoid diverticulum that re-
quired sigmoid resection and colostomy.
The patient’s serum creatinine level continued
to rise to 3.8 mg per deciliter (335.9 µmol per liter),
and his cryocrit remained at 3 percent. Because of
his active infections, the planned oral cyclophos-
phamide treatment was contraindicated. Thus, we
referred him to Dr. Philip C. Amrien of the Hema-
tology and Oncology Unit to be considered for ritux-
imab therapy. At Dr. Amrien’s recommendation, the
patient was treated with rituximab (375 mg per
square meter of body-surface area, intravenously)
weekly for four weeks, according to the standard
protocol. One month later, his creatinine level had
risen to 4.0 mg per deciliter (353.6 µmol per liter).
However, his cryocrit fell to less than 1 percent.
Treatment with mycophenylate mofetil was initiat-
ed, on the basis of the hypothesis that it might serve
as an immunosuppressive agent with less risk of
infection than was associated with cyclophospha-
mide. Oral prednisone (30 mg daily) was continued.
The patient’s cryocrit remained at less than 1 per-
cent, but his creatinine level was still at 3.1 mg per
deciliter (274.0 µmol per liter) three months after he
completed a course of rituximab infusions; hemo-
dialysis was initiated because of uremic symptoms.
To determine whether any active renal disease re-
mained that might benefit from treatment with a
second course of rituximab, a second renal biopsy
was performed.
 
Dr. McCluskey:
 
 A second renal biopsy was per-
formed here about nine months after the first. The
glomeruli showed mild-to-moderate mesangial hy-
percellularity and matrix increase, as well as seg-
mental duplication of the glomerular basement
membrane (Fig. 3A and 3B). There were no intra-
capillary monocytes or pseudothrombi. Several
small arteries showed changes that were indica-
tive of healed arteritis (Fig. 3C). Interstitial fibrosis
and tubular atrophy involved about 40 percent of
the sample. Immunofluorescence microscopical ex-
amination revealed segmental granular glomeru-
lar basement membranes and mesangial staining
for IgM (1+) and C3 (1+ to 3+).
The findings from the second biopsy show some
features of membranoproliferative glomerulone-
phritis type I (Table 3). Lesions such as those in the
specimen can be found in patients with type II mixed
cryoglobulinemic glomerulonephritis who have had
remissions, but similar pathological findings are
 
Figure 2. Skin-Biopsy Specimen.
 
A small dermal vessel is heavily infiltrated by neutrophils 
and mononuclear cells. Extravasated red cells are 
present (hematoxylin and eosin).
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seen in a variety of conditions that have been diag-
nosed as idiopathic or secondary membranoprolif-
erative glomerulonephritis type I.
 
20
 
 Thus, whenever
a pathological diagnosis of membranoproliferative
glomerulonephritis type I is made, tests to rule out
mixed cryoglobulins and hepatitis C infection, and
tests for other infectious agents, should be per-
formed before the condition is labeled idiopathic.
 
Dr. Kay: 
 
Four months after the patient complet-
ed the course of rituximab, his cryocrit again rose
to 3 percent, and he received a second course of ri-
tuximab. Cryoglobulins again became undetect-
able, and he was able to taper off prednisone. One
year after the diagnosis, he was feeling well and be-
gan to be physically active, although he remained
on hemodialysis.
Unfortunately, about 18 months after the diag-
nosis, an enterococcal infection of his hemodialysis
line developed that resulted in bacterial endocardi-
tis of the aortic valve, causing aortic insufficiency
and requiring replacement of the aortic valve with a
bovine bioprosthesis. The patient recovered quick-
ly and now, one year later, is remarkably well, with
an undetectable cryocrit, on chronic hemodialysis.
He is awaiting renal transplantation.
 
Dr. Harris: 
 
The patient and his wife are here at
the conference. Would you like to comment?
 
The Patient: 
 
Until the age of 60, I had been very
healthy and active. Very suddenly, that all changed.
The past three years have been a physical and emo-
tional roller coaster, filled with unpleasant proce-
dures, hope, despair, feeling awful, and feeling al-
most human. The most difficult times have been the
long hospital stays, the endless hours attached to a
dialysis machine, and the stress and frustration of
waiting for answers that didn’t always come quickly.
I have come to appreciate the professionalism
and honesty of my physicians. If they didn’t know
the answers, they kept searching. They were very
open in their discussions about my illness, know-
ing that what they said wasn’t always what I wanted
to hear. They made my wife and me feel an integral
part of a team effort. Throughout this illness, how-
ever, my most valuable asset has been my wife. She
has studied, has learned, has challenged when nec-
essary, and has been an advocate for me — some-
thing all patients should have. I, in turn, have
learned to question and to accept or reject certain
procedures, drugs with unknown results, and phy-
sicians’ opinions and to know that ultimately med-
ical decisions are mine alone.
Type II cryoglobulinemia with renal disease.
 
Dr. Kay reports having served on two advisory boards for
Genentech (after this case was completed).
anatomical diagnosis
 
Figure 3. Second Renal-Biopsy Specimen.
 
The glomerulus (Panel A) exhibits mesangial hypercellu-
larity and increased lobulation, without intracapillary 
monocytes or pseudothrombi (hematoxylin and eosin). 
A glomerulus (Panel B) shows mesangial hypercellulari-
ty and matrix increase (arrowhead), as well as segmental 
duplication of the glomerular basement membrane (ar-
rows, periodic acid–Schiff staining). A small artery (Pan-
el C) shows intimal, medial, and perivascular fibrosis 
(hematoxylin and eosin).
A
B
C
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